A new trading day began on Friday, with Perspective Therapeutics Inc (AMEX: CATX) stock price up 5.38% from the previous day of trading, before settling in for the closing price of $2.23. CATX’s price has ranged from $1.60 to $5.39 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -9.86% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 0.32%. With a float of $61.64 million, this company’s outstanding shares have now reached $74.34 million.
Perspective Therapeutics Inc (CATX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 17.09%, while institutional ownership is 63.29%. The most recent insider transaction that took place on Nov 13 ’25, was worth 22,295. In this transaction Chief Accounting Officer of this company bought 11,000 shares at a rate of $2.03, taking the stock ownership to the 59,800 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Director bought 9,498 for $2.10, making the entire transaction worth $19,946. This insider now owns 9,864 shares in total.
Perspective Therapeutics Inc (CATX) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.24 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.62% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Here are Perspective Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 163.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.52 million. That was better than the volume of 1.08 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 53.85%.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 11.51%, which indicates a significant decrease from 67.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was lower than the 0.27 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.04, while its 200-day Moving Average is $3.03. However, in the short run, Perspective Therapeutics Inc’s stock first resistance to watch stands at $2.41. Second resistance stands at $2.47. The third major resistance level sits at $2.55. If the price goes on to break the first support level at $2.27, it is likely to go to the next support level at $2.19. Assuming the price breaks the second support level, the third support level stands at $2.13.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
With a market capitalization of 174.69 million, the company has a total of 74,338K Shares Outstanding. Currently, annual sales are 1,450 K while annual income is -79,280 K. The company’s previous quarter sales were 210 K while its latest quarter income was -25,970 K.
